Hormonal status in prostatic disease
Frick, J.; Bartsch, G.
Progress in Clinical and Biological Research 6: 143-158
1976
ISSN/ISBN: 0361-7742 PMID: 66687 Document Number: 100378
Document emailed within 1 workday
Related Documents
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161Ferraris, V.; Pacilli, N.; Bottero, G.; Novella, V.; Pisano, P.F.; Buffa, G. 1994: Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy Minerva Urologica e Nefrologica 46(2): 123-128
Bercovici, J.P.; Morfin, R.; Charles, J.F. 1975: Is the prostatic adenoma of hormonal origin La Nouvelle Presse Medicale 4(7): 475-478
Jolobe, O.M.; Khan, A. 1993: Hormonal management of prostatic cancer British Journal of Hospital Medicine 50(8): 493
Lopatkin, N.A.; Goriunov, V.G.; Domurat, B. 1980: Hormonal changes in elderly men with prostatic adenoma Vestnik Akademii Meditsinskikh Nauk SSSR 3: 72-77
McConnell, J.D. 1995: Benign prostatic hyperplasia. Hormonal treatment Urologic Clinics of North America 22(2): 387-400
Studer, U.E.; Altwein, J.; Bartsch, G. 1991: The potential hormonal therapy of prostatic carcinoma Der Urologe. Ausg. a 30(5): 310-316
Forrest, J.B. 1985: Observations on the hormonal response of metastatic prostatic carcinoma Journal of the Oklahoma State Medical Association 78(4): 104-105
Studer, U.E.; Münch, D. 1990: Hormonal therapy (medical orchiectomy) in prostatic carcinoma Schweizerische Medizinische Wochenschrift 120(24): 881-887
Leewansangtong, S.; Soontrapa, S. 1999: Hormonal ablation therapy for metastatic prostatic carcinoma: a review Journal of the Medical Association of Thailand 82(2): 192-205
Aliaev, I.G.; Aslamazov, E.G.; Demidko, I.L. 2010: Quality of life of patients with prostatic cancer under hormonal therapy Urologiia 1: 46; 48-51
Strnad, V.; Riepl, M.; Kühn, R.; Sauer, R. 1996: Radiochemotherapy and simultaneous hormonal therapy of locally advanced prostatic carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 172(4): 225-228
López López, C.; Quilez Fenoll, J.M.; Gómez Ruiz, J.J.; López López, A.F.; Romero Maroto, Y.J. 1996: Histologic regression of localized prostatic tumor with neoadjuvant hormonal therapy Archivos Espanoles de Urologia 49(8): 819-823
Llarena Ibarguren, R.; Zabala Egurrola, J.A.; Acha Pérez, M.; Pertusa Peña, C.; Garibi Undabarrena, J. 1991: Cerebral metastasis of prostatic adenocarcinoma. Hormonal control and review of the literature Archivos Espanoles de Urologia 44(7): 831-832
Maleeva, A.; Tsvetkov, M.; Kekhaĭova, M. 1980: Plasma testosterone: a sound criterion of the effectiveness of hormonal treatment of prostatic carcinoma Vutreshni Bolesti 19(3): 42-46
Servadio, C. 1987: The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma Progress in Clinical and Biological Research 243b: 449-453
Cellini, N.; Luzi, S.; Morganti, A.G.; Balducci, M.; Caiazza, A.; Salvi, G.; Trodella, L.; Valentini, V. 1997: Neoadjuvant combined hormonal therapy and radiotherapy with external beam irradiation in prostatic carcinoma La Radiologia Medica 93(4): 446-450
Barrack, E.R.; Brendler, C.B.; Walsh, P.C. 1987: Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment Progress in Clinical and Biological Research 243a: 79-97
Sakamoto, S.; Kusuyama, H.; Numa, H.; Okada, K. 1989: Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case Hinyokika Kiyo. Acta Urologica Japonica 35(6): 1069-1073
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103